Expertise in
1
conditions

Dr. Yoshihito D. Saito

Hematology
The Queens Medical Center West Oahu Infusion Services
91-2127 Fort Weaver Rd, 
Ewa Beach, HI 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Expertise in
1
conditions
The Queens Medical Center West Oahu Infusion Services
91-2127 Fort Weaver Rd, 
Ewa Beach, HI 

Overview

Yoshihito Saito is a Hematologist practicing medicine in Ewa Beach, Hawaii.

Dr. Saito is highly rated in 1 condition, according to our data. His clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer, Follicular Lymphoma, HER2 Negative Breast Cancer, and Thrombocytopenia.

He is actively involved in clinical research, co-authoring 2 peer reviewed articles and participating in 3 clinical trials. Dr. Saito is currently accepting new patients.

Specialties

Hematology

Licenses

Internal Medicine in HI

Hospital Affiliations

The Queens Medical Center
Kuakini Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
AlohaCare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Hawaii Medical Assurance Association
  • PPO
HMSA
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

The Queens Medical Center West Oahu Infusion Services
91-2127 Fort Weaver Rd, Ewa Beach, HI 96706

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Randomized Phase III Study of Combination Osimertinib (AZD9291) and Bevacizumab Versus Osimertinib (AZD9291) Alone as First-Line Treatment for Patients With Metastatic EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)
Randomized Phase III Study of Combination Osimertinib (AZD9291) and Bevacizumab Versus Osimertinib (AZD9291) Alone as First-Line Treatment for Patients With Metastatic EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)
Enrollment Status: Recruiting
Publish Date: September 03, 2026
Intervention Type: Procedure, Drug, Biological
Study Drugs: Bevacizumab, Osimertinib
Study Phase: Phase 3
A Phase III Randomized Study of Maintenance Nivolumab Versus Observation in Patients With Locally Advanced, Intermediate Risk HPV Positive OPSCC
A Phase III Randomized Study of Maintenance Nivolumab Versus Observation in Patients With Locally Advanced, Intermediate Risk HPV Positive OPSCC
Enrollment Status: Active_not_recruiting
Publish Date: August 04, 2026
Intervention Type: Procedure, Drug, Biological, Radiation, Other
Study Drugs: Cisplatin, Nivolumab
Study Phase: Phase 3
An Open-Label, Phase III Study of Platinum-Gemcitabine With or Without Nivolumab in the First-Line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma
An Open-Label, Phase III Study of Platinum-Gemcitabine With or Without Nivolumab in the First-Line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma
Enrollment Status: Terminated
Publish Date: October 03, 2025
Intervention Type: Drug, Biological, Other
Study Drugs: Carboplatin, Cisplatin, Gemcitabine, Nivolumab
Study Phase: Phase 3
View 2 Less Clinical Trial

2 Total Publications

A solitary brain metastasis as the only site of recurrence of HR positive, HER2 negative breast cancer: a case report and review of the literature.
A solitary brain metastasis as the only site of recurrence of HR positive, HER2 negative breast cancer: a case report and review of the literature.
Journal: Journal of medical case reports
Published: February 11, 2020
Similar Doctors
Expertise in
32
conditions
Expertise in
32
conditions
Referral may be required

Oncology Hematology Care Hawaii Inc.

98-150 Kaonohi St Ste B219, 
Aiea, HI 
 (9.4 miles away)
808-539-2273
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jon Fukumoto is a Hematologist practicing medicine in Aiea, Hawaii. Dr. Fukumoto is highly rated in 32 conditions, according to our data. His clinical expertise encompasses Alpha Thalassemia, Alpha Thalassemia X-Linked Intellectual Disability Syndrome, Thalassemia, Polycythemia Vera, and Bone Marrow Aspiration. Dr. Fukumoto is currently accepting new patients.

Expertise in
17
conditions
Dr. Fariba Navid
Hematology | Oncology
Expertise in
17
conditions
Dr. Fariba Navid
Hematology | Oncology
Referral may be required

Children's Hospital Los Angeles

550 S Beretania St Ste 201, 
Honolulu, HI 
 (12.3 miles away)
323-660-2450
Languages Spoken:
English
See accepted insurances

Fariba Navid is a Hematologist and an Oncologist practicing medicine in Honolulu, Hawaii. Dr. Navid is highly rated in 17 conditions, according to our data. Her clinical expertise encompasses Osteosarcoma, Adult Soft Tissue Sarcoma, Ewing Sarcoma, Neuroblastoma, and Bone Marrow Aspiration.

Expertise in
14
conditions
Dr. Nathan J. Robison
Hematology | Oncology
Expertise in
14
conditions
Dr. Nathan J. Robison
Hematology | Oncology
Referral may be required

Children's Hospital Los Angeles

550 S Beretania St Ste 201, 
Honolulu, HI 
 (12.3 miles away)
323-660-2450
Languages Spoken:
English
See accepted insurances

Nathan Robison is a Hematologist and an Oncologist practicing medicine in Honolulu, Hawaii. Dr. Robison is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Neurofibromatosis, Brain Stem Cancer, Posterior Fossa Tumor, and Glioma.

Frequently Asked Questions about Dr. Yoshihito D. Saito

How do I make an appointment with Dr. Yoshihito D. Saito?

You can book an appointment with Dr. Yoshihito D. Saito by calling their office at 808-691-3777. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Yoshihito D. Saito a top-rated expert for ALK-Positive Non-Small Cell Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Yoshihito D. Saito is classified as an Advanced expert for ALK-Positive Non-Small Cell Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Yoshihito D. Saito specialize in?

While Dr. Yoshihito D. Saito is a Hematology, they have specific expertise in ALK-Positive Non-Small Cell Lung Cancer, Follicular Lymphoma, and HER2 Negative Breast Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Yoshihito D. Saito participate in research or clinical trials?

Yes. Dr. Yoshihito D. Saito has published 2 articles and abstracts on conditions like ALK-Positive Non-Small Cell Lung Cancer. You can view a list of Dr. Yoshihito D. Saito's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Yoshihito D. Saito accept my insurance?

Dr. Yoshihito D. Saito accepts most major insurance plans, including Aetna and AlohaCare. We recommend calling the office directly at 808-691-3777 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Saito's expertise for a condition
ConditionClose
      View All 28 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile